Search results
Results from the WOW.Com Content Network
Raymond A. Costabile (born in 1958 in Washington, DC) is Professor, and Chair Urology with the Department of Urology at the School of Medicine of the University of Virginia. [1] Costabile is a retired Colonel in the US Army and the former Chief of Urology Service at Madigan Army Medical Center. Costabile is an author; [2] his articles on men's ...
Urology. Institutions. Brigham and Women's Hospital. Harvard University. John Hartwell Harrison (February 16, 1909 – January 20, 1984) was an American urologic surgeon, professor, and author. He performed the first human organ removal for transplant to another. This was a pivotal undertaking as a member of the medical team that accomplished ...
Overactive bladder ( OAB) is a common condition where there is a frequent feeling of needing to urinate to a degree that it negatively affects a person's life. [ 2] The frequent need to urinate may occur during the day, at night, or both. [ 4] Loss of bladder control ( urge incontinence) may occur with this condition. [ 1]
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
Marc Goldstein. Marc Goldstein, MD, DSc (hon), FACS is an American urologist and the Matthew P. Hardy Distinguished Professor of Reproductive Medicine, and Urology at Weill Cornell Medical College; Surgeon-in-Chief, Male Reproductive Medicine and Surgery; and Director of the Center of Male Reproductive Medicine and Microsurgery at New York ...
Patrick C. Walsh. Patrick C. Walsh is an American urologist, researcher and writer, best known for developing "the anatomic approach to radical prostatectomy ", involving nerve-sparing techniques which reduced the likelihood of impotence and urinary incontinence.
Prostate cancer screening. Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in men without signs or symptoms. [1] [2] When abnormal prostate tissue or cancer is found early, it may be easier to treat and cure, but it is unclear if early detection reduces mortality rates. [2]
[10] [11] [12] In accordance, bicalutamide is the most widely used antiandrogen in the treatment of prostate cancer. [ 13 ] [ 14 ] [ 15 ] Between January 2007 and December 2009, it accounted in the U.S. for about 87.2% of NSAA prescriptions. [ 16 ]